5.3(top 2%)
Impact Factor
5.7(top 2%)
extended IF
107(top 3%)
H-Index
777
authors
3.5K
papers
91.6K
citations
5.6K
citing journals
31.3K
citing authors

Most Cited Articles of Seminars in Thrombosis and Hemostasis

TitleYearCitations
A critical reappraisal of the bleeding time1990590
Blood rheology and hemodynamics2003573
Fibrinogen as a hemostatic agent2012564
Hyperhomocysteinemia and venous thromboembolism2006541
Description of an in vitro platelet function analyzer--PFA-1001995392
PFA-100 system: a new method for assessment of platelet dysfunction1998367
Platelet dysfunction in renal failure2004312
Platelets: physiology and biochemistry2005312
Hemostasis during normal pregnancy and puerperium2003302
Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon1999275
Hemostasis changes during cardiopulmonary bypass surgery1985270
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis2005266
Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis1995266
Heterogeneity of the tumor vasculature2010250
Pathways and regulation of homocysteine metabolism in mammals2000247
Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock1998238
Clinical utility of the PFA-1002008235
Microparticles in cancer2010228
Platelets and angiogenesis in malignancy2004228
Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis1997226
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists2005225
Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity2005222
Pathophysiology of the thrombophilic state in the cancer patient1999209
Large platelets circulate in an activated state in diabetes mellitus1991204
Regulation of thrombin generation and functions1988204